OasisLMS

Endoscopic ultrasound (EUS) has become integral to the diagnosis and staging of gastrointestinal (GI) and mediastinal mass lesions and conditions. EUS-guided fine needle aspiration (FNA) allows the endoscopist to obtain tissue or fluid for cytological and chemical analysis, adding to the procedure’s utility. Furthermore, the recent development of EUS-guided core biopsy techniques enables histologic sampling in selected cases and for obtaining tissue for molecular analysis in the neoadjuvant and palliative settings. The clinical effectiveness of EUS and EUS-FNA depends upon the judicious use of these techniques. This update integrates new data pertaining to previously-proposed quality indicators and new quality indicators for performing EUS. The prioritized indicators that have wide-ranging clinical application, are associated with variation in practice and outcomes, and are validated in clinical studies.

This webinar will:

• Identify ASGE/ACG endorsed indicators for quality performance of EUS
• Discuss the evidence which supports these indicators and performance targets for these indicators

Sachin Wani, MD, is a clinician and researcher with experience in therapeutic endoscopy. His particular areas of expertise and research include endoscopic ultrasound (EUS) and EUS-guided tissue acquisition techniques in evaluation of gastrointestinal and other malignancies. His areas of research include epidemiology, diagnosis (including advanced imaging techniques) and treatment of patients with Barrett's esophagus and esophageal cancer. His research also focusses on competency assessment in advanced endoscopy training. He co-authored the updated ASGE/ACG paper on Quality Indicators in Endoscopic Ultrasound and has served on the ASGE Quality Assurance in Endoscopy Committee.

This webinar was recorded in 2014.